Pulse cyclophosphamide in the treatment of neuropsychiatric systemic lupus erythematosus

Clinical and Experimental Rheumatology

Volumn 14, Issue 3, 1996, Pages 295-299

  Ramos, P C ^a   Mendez, M J ^a   Ames, P R J ^a   Khamashta, M A ^a   Hughes, G R V ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

brain; cytotoxic drugs; systemic lupus erythematosus

Indexed keywords

CYCLOPHOSPHAMIDE; LUPUS ANTICOAGULANT; PHOSPHOLIPID ANTIBODY;

ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; DRUG RESPONSE; FEMALE; HUMAN; INFECTION; INTRAVENOUS DRUG ADMINISTRATION; LEUKOPENIA; MALE; NEUROPSYCHIATRY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADOLESCENT; ADULT; ANTIRHEUMATIC AGENTS; CHILD; CYCLOPHOSPHAMIDE; DELIRIUM, DEMENTIA, AMNESTIC, COGNITIVE DISORDERS; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; INJECTIONS, INTRAVENOUS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MENTAL DISORDERS; MIDDLE AGED; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 0029778354     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. WEST SG: Neuropsychiatric lupus. Rheum Dis Clin North Am 1994; 20: 129-58.
2. FEINGLASS HJ, ARNETT FC, DORSCH CA, ZIZIC TM, STEVENS MB: Neuropsychiatric manifestations of systemic lupus erythematosus: diagnosis, clinical spectrum, and relationship to other features of disease. Medicine 1976; 55: 323-38.
3. FUTRELL N, SCHULTZ LR, MILLIKAN C: Central nervous system disease in patients with systemic lupus erythematosus. Neurology 1992; 42: 1649-57.
4. BLUESTEIN HG: Neuropsychiatric disorders in systemic lupus erythematosus. In: LAHITA RG (Ed.): Systemic Lupus Erythematosus. New York, J. Wiley & Sons, 1987; 591-614.
5. BRESNIHAN B, OLIVER M, GRIGOR R, HUGHES GRV: Brain reactivity of lymphocytotoxic antibodies in systemic lupus erythematosus with and without cerebral involvement. Clin Exp Immunol 1977; 30: 333-7.
6. FESSEL WJ: Megadose corticosteroid therapy in systemic lupus erythematosus. J Rheumatol 1980; 7: 486-500.
7. ISENBERG DA, MORROW MJW, SNAITH ML: Methyl-prednisolone pulse therapy is the treatment of systemic lupus erythematosus. Ann Rheum Dis 1982; 41: 347-51.
8. BOUMPAS DT, BAREZ S, KLIPPEL JH, BALOW JE: Intermittent cyclophosphamide for the treatment of autoimmune thrombocytopenia in SLE. Ann Intern Med 1990; 112: 674-7.
9. AUSTIN HA, KLIPPEL JH, BALOW JE et al.: Therapy of lupus nephritis: controlled trial of prednisone and cytotoxic drugs. New Engl J Med 1986; 314: 614-9.
10. STEINBERG AP, STEINBERG SC: Long term preservation of renal function in patients with lupus nephritis receiving treatment that includes cyclophosphamide versus those treated with prednisolone only. Arthritis Rheum 1991; 34: 945-55.
11. MCCUNE WJ, GOLBUS J, ZELDES W, BOHLKE P, DUNNE R, FOX DA: Clinical and immunological effects of monthly administration of intravenous cyclophosphamide in severe systemic lupus erythematosus. New Engl J Med 1988; 318: 1423-31.
12. MCCUNE WJ, FOX D: Intravenous cyclophosphamide therapy of severe SLE. Rheum Dis Clin North Am 1989; 15: 455-77.
13. VON FELDT JM, OSTROV BC, CALLEGARI PE: The use of cyclophosphamide in the treatment of CNS Lupus. Arthritis Rheum 1991; 43: S187 (Abstract).
14. BOUMPAS DT, YAMADA H, PATRONAS NJ, SCOTT D, KLIPPEL JH, BALOW JE: Pulse cyclophosphamide for severe neuropsychiatric lupus. Q J Med 1991; 81: 975-84.
15. NEUWELT CM, LACKS S, KAYE BR, ELLMAN JB, BORENSTEIN DG: Role of intravenous cyclophosphamide in the treatment of severe neuropsychiatric systemic lupus erythematosus. Am J Med 1995; 98: 32-41.
16. TAN EM, COHEN AS, FRIES JF, et al.: The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271-7.
17. SINGER J, DENBURG JA, and the AD HOC NEUROPSYCHIATRIC LUPUS WORKSHOP GROUP: Diagnostic criteria for neuropsychiatric systemic lupus erythematosus: the results of a consensus meeting. J Rheumatol 1990; 17: 1397-1402.
18. TOUBI E, KHAMASHTA MA, PANARRA A, HUGHES GRV: Association of antiphospholipid antibodies with central nervous system disease in systemic lupus erythematosus. Am J Med 1995; 99: 397-401.
19. STIMMLER M, COLETTI PM, QUISMORIO FP: Magnetic resonance imaging of the brain in neuropsychiatric systemic lupus erythematosus. Semin Arthritis Rheum 1993; 22: 335-49.
20. AISEN AM, GABRIELSEN TO, MCCUNE WJ: MR imaging of systemic lupus erythematosus. Arthritis Rheum 1992; 35: 1330-42.
21. HOUSSIAU FA, D'CRUZ DP, HAGA HJ, HUGHES GRV: Short course of weekly low-dose intravenous pulse cyclophosphamide in the treatment of lupus nephritis: a preliminary study. Lupus 1991; 1: 31-5.
22. HAGA HJ, D'CRUZ DP, ASHERSON RA, HUGHES GRV: Short term effects of intravenous pulses of cyclophosphamide in the treatment of connective tissue disease crisis. Ann Rheum Dis 1992; 51: 885-8.
23. KHAMASHTA MA, HUGHES GRV: Detection and importance of anticardiolipin antibodies. J Clin Pathol 1993; 46: 104-7.
24. THIAGARAJAN P, PENGO V, SHAPIRO SS: The use of the dilute Russell viper venom time for the diagnosis of lupus anticoagulant. Blood 1986; 68: 869-74.
25. HUGHES GRV: Central nervous system lupus - Diagnosis and treatment. J Rheumatol 1980; 7: 405-11.
26. CUPPS TR, EDGAR LC, FAUCI AS: Immunosuppression of human B lymphocyte function by cyclophosphamide. J Immunol 1988; 128: 2453-7.
27. HURD E: Immunosuppressive and antiinflammatory properties of cyclophosphamide, azathioprine and methotrexate. Arthritis Rheum 1973; 16: 88-91.